Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2005 Jul;42(7):565–576. doi: 10.1136/jmg.2004.029835

STRA13 expression and subcellular localisation in normal and tumour tissues: implications for use as a diagnostic and differentiation marker

A Ivanova 1, S Liao 1, M Lerman 1, S Ivanov 1, E Stanbridge 1
PMCID: PMC1736099  PMID: 15994878

Abstract

Background: STRA13 is a bHLH transcription factor that plays a crucial role in cell differentiation, proliferation, apoptosis, and response to hypoxia.

Objective: To assess STRA13 involvement in carcinogenesis and evaluate its diagnostic value.

Methods: A comprehensive analysis was undertaken of the endogenous protein expression in 389 normal and corresponding malignant specimens, using newly generated polyclonal antibodies.

Results: STRA13 was commonly expressed in epithelial cells of normal and neoplastic tissues where it was confined mostly to the nucleus. Intense cytoplasmic STRA13 immunoreactivity was characteristic of myoepithelial and differentiated squamous epithelial cells of all organ sites and their neoplastic counterparts, suggesting application of STRA13 as a myoepithelial cell marker. A distinctive apical granular cytoplasmic staining pattern observed in the pancreas and large intestine was retained in corresponding metastatic carcinomas, providing for identification of the primary sites of these disseminating tumours. In less differentiated tumours there was a tendency to lose the cytoplasmic staining or to switch to nuclear STRA13 staining. Analysis of STRA13, HIF-1α, and CAIX expression patterns in a large set of various tumours substantiated the association of STRA13 with HIF-1α expression and hypoxia in vivo. Investigation of the molecular mechanisms of STRA13 nucleo-cytoplasmic shuttling suggested that STRA13 employs nuclear import/export that utilises the NLS/NES motifs situated within the N-terminus and in the middle of the protein.

Conclusions: STRA13 may serve as a marker for myoepithelial cells, for the degree of tumour differentiation, and for identification of the primary site of certain metastatic tumours. In combination with CAIX and CAXII markers, it may lead to a more accurate classification of all renal carcinomas.

Full Text

The Full Text of this article is available as a PDF (788.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apostolova Margarita D., Ivanova Iordanka A., Dagnino Carla, D'Souza Sudhir J. A., Dagnino Lina. Active nuclear import and export pathways regulate E2F-5 subcellular localization. J Biol Chem. 2002 Jun 27;277(37):34471–34479. doi: 10.1074/jbc.M205827200. [DOI] [PubMed] [Google Scholar]
  2. Beasley N. J., Wykoff C. C., Watson P. H., Leek R., Turley H., Gatter K., Pastorek J., Cox G. J., Ratcliffe P., Harris A. L. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res. 2001 Jul 1;61(13):5262–5267. [PubMed] [Google Scholar]
  3. Boudjelal M., Taneja R., Matsubara S., Bouillet P., Dolle P., Chambon P. Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic helix-loop-helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells. Genes Dev. 1997 Aug 15;11(16):2052–2065. doi: 10.1101/gad.11.16.2052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chakrabarti J., Turley H., Campo L., Han C., Harris A. L., Gatter K. C., Fox S. B. The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers. Br J Cancer. 2004 Aug 31;91(5):954–958. doi: 10.1038/sj.bjc.6602059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Giatromanolaki A., Koukourakis M. I., Sivridis E., Pastorek J., Wykoff C. C., Gatter K. C., Harris A. L. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res. 2001 Nov 1;61(21):7992–7998. [PubMed] [Google Scholar]
  6. Giatromanolaki Alexandra, Koukourakis Michael I., Sivridis Efthimios, Turley Helen, Wykoff Charles C., Gatter Kevin C., Harris Adrian L. DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer. J Pathol. 2003 Jun;200(2):222–228. doi: 10.1002/path.1330. [DOI] [PubMed] [Google Scholar]
  7. Honma Sato, Kawamoto Takeshi, Takagi Yumiko, Fujimoto Katsumi, Sato Fuyuki, Noshiro Mitsuhide, Kato Yukio, Honma Ken-ichi. Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature. 2002 Oct 24;419(6909):841–844. doi: 10.1038/nature01123. [DOI] [PubMed] [Google Scholar]
  8. Hood J. K., Silver P. A. In or out? Regulating nuclear transport. Curr Opin Cell Biol. 1999 Apr;11(2):241–247. doi: 10.1016/s0955-0674(99)80032-5. [DOI] [PubMed] [Google Scholar]
  9. Hoskin P. J., Sibtain A., Daley F. M., Wilson G. D. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer. 2003 Oct 6;89(7):1290–1297. doi: 10.1038/sj.bjc.6601260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ivanov S. V., Kuzmin I., Wei M. H., Pack S., Geil L., Johnson B. E., Stanbridge E. J., Lerman M. I. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12596–12601. doi: 10.1073/pnas.95.21.12596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ivanov S., Liao S. Y., Ivanova A., Danilkovitch-Miagkova A., Tarasova N., Weirich G., Merrill M. J., Proescholdt M. A., Oldfield E. H., Lee J. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol. 2001 Mar;158(3):905–919. doi: 10.1016/S0002-9440(10)64038-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ivanova A. V., Ivanov S. V., Danilkovitch-Miagkova A., Lerman M. I. Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway. J Biol Chem. 2001 Feb 6;276(18):15306–15315. doi: 10.1074/jbc.M010516200. [DOI] [PubMed] [Google Scholar]
  13. Ivanova A. V., Ivanov S. V., Zhang X., Ivanov V. N., Timofeeva O. A., Lerman M. I. STRA13 interacts with STAT3 and modulates transcription of STAT3-dependent targets. J Mol Biol. 2004 Jul 16;340(4):641–653. doi: 10.1016/j.jmb.2004.05.025. [DOI] [PubMed] [Google Scholar]
  14. Liao S. Y., Brewer C., Závada J., Pastorek J., Pastorekova S., Manetta A., Berman M. L., DiSaia P. J., Stanbridge E. J. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol. 1994 Sep;145(3):598–609. [PMC free article] [PubMed] [Google Scholar]
  15. Liao S. Y., Stanbridge E. J. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia. Cancer Epidemiol Biomarkers Prev. 1996 Jul;5(7):549–557. [PubMed] [Google Scholar]
  16. Loncaster J. A., Harris A. L., Davidson S. E., Logue J. P., Hunter R. D., Wycoff C. C., Pastorek J., Ratcliffe P. J., Stratford I. J., West C. M. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res. 2001 Sep 1;61(17):6394–6399. [PubMed] [Google Scholar]
  17. Ossareh-Nazari B., Gwizdek C., Dargemont C. Protein export from the nucleus. Traffic. 2001 Oct;2(10):684–689. doi: 10.1034/j.1600-0854.2001.21002.x. [DOI] [PubMed] [Google Scholar]
  18. Potter C. P. S., Harris A. L. Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer. Br J Cancer. 2003 Jul 7;89(1):2–7. doi: 10.1038/sj.bjc.6600936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Seimiya Mika, Wada Akihiko, Kawamura Kiyoko, Sakamoto Akemi, Ohkubo Yusuke, Okada Seiji, Hatano Masahiko, Tokuhisa Takeshi, Watanabe Takeshi, Saisho Hiromitsu. Impaired lymphocyte development and function in Clast5/Stra13/DEC1-transgenic mice. Eur J Immunol. 2004 May;34(5):1322–1332. doi: 10.1002/eji.200324700. [DOI] [PubMed] [Google Scholar]
  20. Shen Ming, Yoshida Eri, Yan Weiqun, Kawamoto Takeshi, Suardita Ketut, Koyano Yasuhiko, Fujimoto Katsumi, Noshiro Mitsuhide, Kato Yukio. Basic helix-loop-helix protein DEC1 promotes chondrocyte differentiation at the early and terminal stages. J Biol Chem. 2002 Oct 15;277(51):50112–50120. doi: 10.1074/jbc.M206771200. [DOI] [PubMed] [Google Scholar]
  21. Sternlicht M. D., Kedeshian P., Shao Z. M., Safarians S., Barsky S. H. The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res. 1997 Nov;3(11):1949–1958. [PubMed] [Google Scholar]
  22. Sun H., Lu B., Li R. Q., Flavell R. A., Taneja R. Defective T cell activation and autoimmune disorder in Stra13-deficient mice. Nat Immunol. 2001 Nov;2(11):1040–1047. doi: 10.1038/ni721. [DOI] [PubMed] [Google Scholar]
  23. Sun H., Taneja R. Stra13 expression is associated with growth arrest and represses transcription through histone deacetylase (HDAC)-dependent and HDAC-independent mechanisms. Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4058–4063. doi: 10.1073/pnas.070526297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Turley Helen, Wykoff Charles C., Troup Sandra, Watson Peter H., Gatter Kevin C., Harris Adrian L. The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in human tissues and tumours. J Pathol. 2004 Jul;203(3):808–813. doi: 10.1002/path.1585. [DOI] [PubMed] [Google Scholar]
  25. Wykoff C. C., Beasley N. J., Watson P. H., Turner K. J., Pastorek J., Sibtain A., Wilson G. D., Turley H., Talks K. L., Maxwell P. H. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 2000 Dec 15;60(24):7075–7083. [PubMed] [Google Scholar]
  26. Yun Zhong, Maecker Heather L., Johnson Randall S., Giaccia Amato J. Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell. 2002 Mar;2(3):331–341. doi: 10.1016/s1534-5807(02)00131-4. [DOI] [PubMed] [Google Scholar]
  27. Zawel Leigh, Yu Jian, Torrance Christopher J., Markowitz Sanford, Kinzler Kenneth W., Vogelstein Bert, Zhou Shibin. DEC1 is a downstream target of TGF-beta with sequence-specific transcriptional repressor activities. Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2848–2853. doi: 10.1073/pnas.261714999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Zhao X., Ito A., Kane C. D., Liao T. S., Bolger T. A., Lemrow S. M., Means A. R., Yao T. P. The modular nature of histone deacetylase HDAC4 confers phosphorylation-dependent intracellular trafficking. J Biol Chem. 2001 Jul 24;276(37):35042–35048. doi: 10.1074/jbc.M105086200. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES